MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. BIIB
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

Biogen (BIIB) Other Ratios & Metrics 2020-2026

ROE, ROA, asset turnover, revenue per share, and interest coverage

Others

Return ratios, efficiency, and credit metrics

ROE
7.4%
ROA
4.7%
Asset Turnover
0.3
Rev/Share
$67.51
Interest Coverage
5.6
ROE of 7.4% indicates weak profitability — below most peers. ROA of 4.7% shows how efficiently management uses assets to generate profit. Revenue per share at $67.51 removes dilution effects from top-line growth. Interest coverage of 5.6x means the company comfortably covers its interest obligations.
Return on Equity (ROE)
15%+ consistently signals a durable competitive advantage
Return on Assets (ROA)
How well management uses assets to generate profit
Asset Turnover
How efficiently assets generate each dollar of sales
Revenue per Share
Per-share revenue growth adjusted for dilution
Interest Coverage
How comfortably the company covers interest payments